glp-1 drugs semaglutide GLP-1s for Weight Loss: What You Need to Know Medicare will negotiate Novo's GLP-1

Explore Fridays' weight loss program pricing model

Summary Retatrutide, a triple agonist now in phase 3 trials, has the potential to become the most effective pharmacological treatment for obesity while also offering substantial benefits in T2D management and other cardiometabolic risk factors.

2 GLP-1R monotherapy (e.g., semaglutide) is highly effective, but dual GLP-1R/GIPR agonists (e.g.,

Explore the latest data, usage trends, and what rising demand means for public health and the weight-loss market.

Does GLP-1 help with depression

Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option